Omicron: call for updated vaccines.

Clicks: 176
ID: 274881
2021
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #34 of 39 articles by views in Journal of medical virology

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
The Omicron SARS-CoV-2 variant was potentially generated from a chronically infected COVID-19 patient vaccinated with an mRNA- or non-mRNA-based vaccine, offering the opportunity for the virus to evolve and mutate in order to evade the body's immune response. To understand the significance of this SARS-CoV-2 variant and what it means for the global response to the pandemic, vaccinologists should systematically evaluate the role of mRNA- and non-mRNA-based vaccines in the generation of novel SARS-CoV-2 variants, including variants of concern (VOCs) and interest (VOIs), that occur via breakthrough vaccine-elicited immunity. Although COVID vaccine boosters are likely to offer some protection and mRNA- or non-mRNA-based vaccines can be adapted to new variants, such as Omicron, the requirement of a booster so soon after full vaccination, with further shots potentially required, is of concern given the impacts on human health. Therefore, in the race to protect the global population against novel SARS-CoV-2 VOCs and VOIs, there is an urgent need to create much more effective one-dose vaccines that can protect people over their entire lifetime. This article is protected by copyright. All rights reserved.
Reference Key
li2021omicronjournal Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Li, Xingguang;
Journal Journal of medical virology
Year 2021
DOI
10.1002/jmv.27530
URL
Keywords
vocs covid-19 sars-cov-2 vois

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.